| pubmed-article:12677469 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12677469 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12677469 | lifeskim:mentions | umls-concept:C0064636 | lld:lifeskim |
| pubmed-article:12677469 | lifeskim:mentions | umls-concept:C0236788 | lld:lifeskim |
| pubmed-article:12677469 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12677469 | pubmed:dateCreated | 2003-4-4 | lld:pubmed |
| pubmed-article:12677469 | pubmed:abstractText | This study analyzes the effectiveness and safety of lamotrigine in the treatment of bipolar II disorder. Patients and methods. Seventeen patients with DSM-IV bipolar II disorder with a history of poor response to lithium or other mood-stabilizers gave their consent to be treated with lamotrigine. Th ey we re followed-up for 6 months and assessed with the Young Mania Scale (YMRS), Hamilton Depression Rating Scale (HDRS-17) and the modified version of the Global Clinic Impresion Scale for Bipolar Disorder ( CG I-BP-M). | lld:pubmed |
| pubmed-article:12677469 | pubmed:language | spa | lld:pubmed |
| pubmed-article:12677469 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12677469 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12677469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12677469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12677469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12677469 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12677469 | pubmed:issn | 1139-9287 | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:TorrentCC | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:GastóCC | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:VietaEE | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:CometRR | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:ColonGG | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:BenabarreAA | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:ReinaresMM | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:CorbellaBB | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:GoikoleaMM | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:MartInez-Arán... | lld:pubmed |
| pubmed-article:12677469 | pubmed:author | pubmed-author:ParramonGG | lld:pubmed |
| pubmed-article:12677469 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12677469 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:12677469 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12677469 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12677469 | pubmed:pagination | 65-8 | lld:pubmed |
| pubmed-article:12677469 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:meshHeading | pubmed-meshheading:12677469... | lld:pubmed |
| pubmed-article:12677469 | pubmed:articleTitle | [Treatment of bipolar II disorder with lamotrigine]. | lld:pubmed |
| pubmed-article:12677469 | pubmed:affiliation | Programa de Transtornos Bipolares, Centro del Stanley Medical Research Insstitute de Barcelona. Hospital Clínico, IDIBAPS, Barcelona, Spain. EVIETA@clinic.ub.es | lld:pubmed |
| pubmed-article:12677469 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12677469 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12677469 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:12677469 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
